Temozolomide
- All
- News
-
A New Combination Therapy Can Improve Survival Rate in Brain Cancer Patients
The vaccine targeting CMV antigen pp65, combined with temozolomide, improved both progression-free survival and overall survival for a small group of GBM patients.
-
Drug That Could Limit Spread of Deadly Brain Tumours
The drug propentofylline or PPF, increases the effectiveness of a standard-of-care chemotherapy drug called temozolomide (TMZ), and radiation, to treat glioblastoma.
-
Genes Influence Cancer Treatment Outcomes
A person's response to anti-cancer drug treatments is strongly related to his or her genetic ancestry, says new research.
-
A New Combination Therapy Can Improve Survival Rate in Brain Cancer Patients
The vaccine targeting CMV antigen pp65, combined with temozolomide, improved both progression-free survival and overall survival for a small group of GBM patients.
-
Drug That Could Limit Spread of Deadly Brain Tumours
The drug propentofylline or PPF, increases the effectiveness of a standard-of-care chemotherapy drug called temozolomide (TMZ), and radiation, to treat glioblastoma.
-
Genes Influence Cancer Treatment Outcomes
A person's response to anti-cancer drug treatments is strongly related to his or her genetic ancestry, says new research.
